Text
10 principles summarizing SynBalance's belief about taking care of people’s health.
Gastroenterology
The findings of a recent study suggest that other gut microbes use liquid-liquid phase separation to colonize the gut, opening the way for new microbiota-based clinical applications.
Gastroenterology, Neuroscience
The findings of a recent study suggest that estradiol-degrading bacteria could be therapeutic targets for treating depression in some women.
Industry
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology, which provides greater…
Industry
First and only FDA-approved orally administered microbiota-based therapeutic, validating Seres’ microbiome platform –
Industry
The VE303 study would be the first pivotal Phase 3 study of a therapeutic candidate based on a defined bacterial consortium, which Vedanta is pioneering as a next-generation approach to…
Gastroenterology, Oncology
The findings of a recent study suggest that tilimycin-producing bacteria can cause genetic mutations in the colon and increase a person’s susceptibility to disease.
Gastroenterology, Neuroscience
The study reveals a connection between gut microbiome changes and the most prevalent form of alcohol misuse in adolescence, occurring even before the onset of addiction.
Oncology
The findings of a new study shed light on a general mechanism by which gut bacteria may influence anti-cancer immune responses.
Gastroenterology, Pediatrics
The findings of a new study suggest that mothers transmit bacteria to their infants through multiple routes — a process that ensures that babies receive essential microbes.